A Bland-Altman Comparison of the Lead Care® System and Inductively Coupled Plasma Mass Spectrometry for Detecting Low-Level Lead in Child Whole Blood Samples

Journal of Medical Toxicology

Volumn 7, Issue 1, 2011, Pages 24-32

  Sobin, Christina ^a,b   Parisi, Natali ^c   Schaub, Tanner ^c   de la Riva, Eva ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c NEW MEXICO STATE UNIVERSITY   (United States)

Author keywords

Bland Altman; Blood lead analysis; Inductively coupled plasma mass spectrometry; Pb; Pediatric neurotoxicology

Indexed keywords

LEAD;

ACCURACY; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD SAMPLING; CHILD; CHILD CARE; CLINICAL EVALUATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; LEAD BLOOD LEVEL; MALE; MASS SPECTROMETRY; MEASUREMENT ERROR; NEUROTOXICITY; PRESCHOOL CHILD; REPRODUCIBILITY; RISK FACTOR; SCHOOL CHILD;

BLOOD CHEMICAL ANALYSIS; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; ELECTROCHEMICAL TECHNIQUES; FEMALE; HUMANS; LEAD; LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD; LIMIT OF DETECTION; MALE; MASS SCREENING; MASS SPECTROMETRY; MICROCHEMISTRY; REPRODUCIBILITY OF RESULTS; STATISTICS AS TOPIC;

EID: 79952618444     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-010-0113-7     Document Type: Article

References (19)

1. Documentation for the Final 2002 Point Source National Emissions Inventory. US Environmental Protection Agency, 2006, U. S. Environmental Protection Agency: Emission Inventory and Analysis Group Air Quality and Analysis Division, Research Triangle Park, NC 27711.
2. Gilbert SG, Weiss B (2006) A rationale for lowering the blood lead action level from 10 to 2 [mu]/dL. Neurotoxicology 27(5): 693-701.
3. Center for Disease Control and Prevention (2000) Recommendations for blood lead screening of young children enrolled in medicaid: targeting a group at high risk, in mobidity and mortality weekly report. Center for Disease Control and Prevention, Atlanta, pp 1-13.
4. Recommendations for blood lead screening of young children enrolled in medicaid: targeting a group at high risk, in Morbidity and Mortality Weekly Report. Center for Disease Control and Prevention, 2000, Center for Disease Control and Prevention: Atlanta. p. 1-13.
5. Taylor L et al (2001) Evaluation of a portable blood lead analyzer with occupationally exposed populations. Am J Ind Med 40(4): 354-362.
6. Pineau A et al (2002) Determination of lead in whole blood: comparison of the leadcare blood lead testing system with Zeeman longitudinal electrothermal atomic absorption spectrometry. J Trace Elem Med Biol 16(2): 113-117.
7. Shannon MW, Rafai N (1997) The accuracy of a portable instrument for analysis of blood lead in children. Ambul Child Health 3: 249-254.
8. Zentner LEA, Rondo PHC, Latorre MRDO (2005) Blood lead concentrations in maternal and cord blood evaluated by two analytic methods. Ach Environ Occup Health 60(1): 47-50.
9. Bland, J. M., Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1986. i: p. 307-310.
10. Dewitte K et al (2002) Application of the Bland-Altman plot for interpretation of method-comparison studies: a critical investigation of its practice. Clin Chem 48(5): 799-801.
11. Wang J, Tian B (1992) Screen-printed stripping voltammetric/potentiometric electrodes for decentralized testing of trace lead. Anal Chem 64(15): 1706-1709.
12. Mantha S et al (2000) Comparing methods of clinical measurement: reporting standards for Bland and Altman analysis. Anesth Analg 90(3): 593-602.
13. US Department of Health and Human Services (1991) Preventing lead poisoning in young children: a statement by the Centers for Disease Control, in Report No. 99-2230. Centers for Disease Control and Prevention. US Department of Health and Human Services: Atlanta, GA.
14. Centers for Disease Control and Prevention (CDC) (1991) Preventing lead poisoning in young children: A statement by the US Department of Health and Human Services. US Government Printing Office, Atlanta (No. 537).
15. Hamilton C, Stamey J (2007) Using Bland-Altman to assess agreement between two medical devices-don't forget the confidence intervals! J Clin Monit Computing 21(6): 331-333.
16. Chiodo LM et al (2007) Blood lead levels and specific attention effects in young children. Neurotoxicol Teratol 29(5): 538-546.
17. Chiodo LM, Jacobson SW, Jacobson JL (2004) Neurodevelopmental effects of postnatal lead exposure at very low levels. Neurotoxicol Teratol 26(3): 359-371.
18. Min J-Y et al (2007) Neurobehavioral function in children with low blood lead concentrations. Neurotoxicology 28(2): 421-425.
19. Surkan PJ et al (2007) Neuropsychological function in children with blood lead levels & 10 [mu]g/dL. Neurotoxicology 28(6): 1170-1177.